Pancreatic neuroendocrine neoplasms include mainly well-differentiated neuroendocrine
tumors but also rare poorly differentiated neuroendocrine carcinomas. Molecular …

Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Context.—Since the initial description of pancreatic endocrine physiology and the
recognition of islet cell tumors in the 1800s, there have been noteworthy advances in the …

Pancreatic neuroendocrine tumors (PNETs), a group of endocrine tumors arising in the
pancreas, are among the most common neuroendocrine tumors. The genetic causes of …

Pancreatic neuroendocrine carcinoma is a rare aggressive tumor commonly harboring TP53
and RB1 alterations and lacking neuroendocrine-related genetic changes such as mutations …

Pancreatic neuroendocrine neoplasms include well-differentiated pancreatic
neuroendocrine tumors (PanNETs) and neuroendocrine carcinomas (NECs) with well …

Pancreatic neuroendocrine tumors (NETs) are a heterogeneous group of tumors. Despite
being relatively rare, representing just 1–2% of all pancreatic neoplasms, the incidence of …

Pancreatic neuroendocrine neoplasms (panNENs) are the second most common epithelial
tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it …

Pancreatic endocrine tumors (PETs) are rare neoplasms which account for 1% to 2% of all
pancreatic malignancies. The diagnostic, grading and prognostic criteria for PETs have …

Pancreatic endocrine tumors (PETs) continue to be challenging diagnostic and prognostic
lesions in surgical pathology and clinical medicine. These neoplasms can be graded into 1 …